Portfolio
Companies building the instruments, platforms, and software of modern biology.
Active investments, plus prior companies founded or backed by our partners before the launch of Phase Two Ventures.
Active
Current investments
Augment Biologics
Next-gen glycoengineering for better biologics.
GelTech Labs
Lab automation for hydrogel scientists.
Visit site →
Acurion
Transforming routine pathology slides into powerful diagnostic insights.
Visit site →
Navega Therapeutics
AI-enabled zinc finger platform for gene therapies based on targeted epigenetic regulation.
Visit site →
Morphos Bioscience
Spatial biology platform that maps tissues using standard sequencing.
Visit site →
Potato
Autonomous agents for science and literature-based tools to plan and run new methods.
Visit site →
Exthymic
Making autologous cell therapies more accessible through point-of-care manufacturing.
Visit site →
Rybodyn
Platform to unlock the dark proteome for novel drug target discovery.
Visit site →
Andson Biotech
Sample prep and data analytics solutions for mass spectrometry workflows.
Visit site →
Defined Bioscience
Cell culture reagents to consistently grow stem cells and iPSC-derived tissue.
Visit site →
Lynx Biosciences
Resolving cancer biology through integrated multi-omics.
Visit site →Prior
Before Phase Two Ventures
Companies our partners founded, operated, or invested in prior to the launch of the fund — including two acquisitions.
NanoCellect Biomedical*
Microfluidic cell sorting technology for single-cell cloning and genomics.
Acquired by Nova Biomedical
Visit site →
Arima Genomics*
3D genomics providing both the sequence and structure of the genome.
Visit site →
Novoron Bioscience*
Restoring the regenerative capacity of the brain and spinal cord.
Visit site →
ScholarNexus*
Life science startup accelerator.
Sweetspot Diabetes*
Health data company improving the use of data in diabetes treatment.
Acquired by Dexcom
Mesa Biotech*
Test and data company providing infectious disease diagnostics.
Acquired by Thermo Fisher
Building the tools for tech + bio?
We back pre-seed and seed founders in life science tools, platform technologies, and AI x Bio.